Orphans of pharmacological research? Importance of chemical-synthetic antitussives and expectorants;Waisenkinder der pharmakologischen forschung? Stellenwert chemischsynthetischer antitussiva und expektorantien

Pharmazie in Unserer Zeit

Volumn 37, Issue 6, 2008, Pages 472-476

  Kardos, Peter ^a  

^a Schlafmedizin Klinik Maingau Vom Roten Kreuz   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ANTITUSSIVE AGENT; BROMHEXINE; CARBOCISTEINE; CHLORPHENIRAMINE; CINEOLE; CODEINE; CODIPRONT; DEXBROMPHENIRAMINE; DEXTROMETHORPHAN; DIHYDROCODEINE; DIPHENHYDRAMINE; EXPECTORANT AGENT; FAGUSAN; GUAIFENESIN; HYDROCODONE; LEVDROPROPIZINE; LONGTUSSIN; MORPHINE SULFATE; NEO TUSSAN; NOSCAPINE; PENTOXYVERINE; QUIMBO; UNCLASSIFIED DRUG;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DRUG RESEARCH; EVIDENCE BASED MEDICINE; FIBROSING ALVEOLITIS; FOOD AND DRUG ADMINISTRATION; HUMAN; SHORT SURVEY; ANIMAL; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECT; PERIPHERAL NERVOUS SYSTEM; REVIEW;

ANIMALS; ANTITUSSIVE AGENTS; CENTRAL NERVOUS SYSTEM; COUGH; EXPECTORANTS; HUMANS; PERIPHERAL NERVOUS SYSTEM;

EID: 56549105492     PISSN: 00483664     EISSN: 16151003     Source Type: Journal    
DOI: 10.1002/pauz.200800286     Document Type: Short Survey

References (11)

1. Dicpinigaitis, P.V., Gayle, Y.E.: Effect of guaifenesin on cough reflex sensitivity. Chest 124 (2003), 2178-2181.
2. Kardos, P., Gebhardt, T.: Chronisch persistierender Husten (CPH) in der Praxis: Diagnostik und Therapie bei 329 Patienten in 2 Jahren. Pneumologie 50 (1996), 437-441.
3. Eccles, R.: Codeine, Cough And Upper Respiratory Infection. Pulm. Pharmacol. 9 (1996), 293-297.
4. Smith, J., Owen, E., Earis, J., et al.: Cough in COPD: Correlation of Objective Monitoring With Cough Challenge and Subjective Assessments. Chest 130 (2006), 379-385.
5. Morice, A.H., Menon, M.S., Mulrennan, S.A., et al.: Opiate Therapy in Chronic Cough. Am. J. Respir. Crit. Care Med. 175 (2007), 312-315.
6. Bolser, D.C.: Older-generation antihistamines and cough due to upper airway cough syndrome (UACS): Efficacy and mechanism. Lung 186 (Suppl 1) (2008), S74-S77.
7. Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P.N., et al.: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365 (2005), 1552-1560.
8. Association of the European Self-Medication Industry. www.AESGP.be/encour/frame.html (letzter Zugriff 18.7.2008).
9. Eccles, R.: The powerful placebo in cough studies? Pulm. Pharmacol. Ther. 15 (2002), 303-308.
10. Gillissen, A., Nowak, D.: Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir. Med. 92 (1998), 609-623.
11. Demedts, M., Behr, J., Buhl, R., et al.: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 353 (2005), 2229-2242.